AKT1 and cystic fibrosis: miRNA-155, upregulated in aging and suspected to contribute to inflammation-associated stem cell dysfunction (Teramura and Onodera, 2018), is highly expressed in CF lung epithelial cells and blood neutrophils, where it reduces SHIP1 levels promoting PI3K/Akt activation that drives IL-8 expression